M. Lazzero

发表

Plasma fibrinogen levels and restenosis after primary percutaneous coronary intervention

G. Bellomo, A. Rognoni, C. Mario, 2012, Journal of Thrombosis and Thrombolysis.

Below normal pre-procedural cardiac troponin I levels are associated with an adverse prognosis after percutaneous coronary interventions.

A. Jaffe, G. Bellomo, A. Rognoni, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Pre-hospital ticagrelor in patients with ST-segment elevation myocardial infarction with long transport time to primary PCI facility.

I. Porto, A. Rognoni, A. Lupi, 2016, Cardiovascular revascularization medicine : including molecular interventions.

Comparison of the novel Angio-Seal Evolution with Angio-Seal STS closure device.

C. Di Mario, A. Rognoni, G. Secco, 2012, Perspectives in vascular surgery and endovascular therapy.

C. Di Mario, R. Fattori, G. Bellomo, 2015, Journal of cardiovascular medicine.

Drug-Eluting Stents vs. Bare Metal Stents in Saphenous Vein Graft Disease

E. Navarese, S. Servi, A. Lupi, 2011 .

Drug-eluting stents vs. bare metal stents in saphenous vein graft disease. Insights from a meta-analysis of 7,090 patients.

S. de Servi, E. Navarese, A. Lupi, 2011, Circulation journal : official journal of the Japanese Circulation Society.

Safety and efficacy of the new Angio-Seal Evolution™ closure device: a single-center experience.

L. Plebani, A. Lupi, M. Lazzero, 2011, The Journal of invasive cardiology.

Intracoronary bivalirudin: a new way to appease the hostile thrombus?

I. Porto, A. Rognoni, G. Secco, 2013, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Transradial Primary Angioplasty in a Patient With Congenital Abnormality of the Forearm Circulation and Increased Bleeding Risk

A. Rognoni, A. Lupi, M. Lazzero, 2011 .

Different spectrum of vascular complications after angio-seal deployment or manual compression.

A. Rognoni, G. Secco, L. Plebani, 2012, The Journal of invasive cardiology.

Levosimendan: from basic science to clinical trials.

A. Rognoni, G. Rognoni, A. Lupi, 2011, Recent patents on cardiovascular drug discovery.

[Death after ST-elevation myocardial infarction in patients treated with fibrinolytic therapy, angioplasty, or conventional therapy. A post-mortem study to verify cardiac rupture as a cause of death].

L. Rossi, M. Lazzero, A. S. Bongo, 2008, Giornale italiano di cardiologia.

Relationship Between Left Atrial Volume and Atrial Fibrillation Following Coronary Artery Bypass Grafting

A. Lupi, L. Rossi, M. Lazzero, 2012, Journal of cardiac surgery.

Meta‐analysis of bioabsorbable versus durable polymer drug‐eluting stents in 20,005 patients with coronary artery disease: An update

I. Porto, R. Fattori, A. Rognoni, 2014, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Biodegradable versus durable polymer drug eluting stents in coronary artery disease: Insights from a meta-analysis of 5834 patients

R. Fattori, A. Rognoni, I. Sheiban, 2014, European journal of preventive cardiology.

Drug eluting balloon versus drug eluting stent in percutaneous coronary interventions: insights from a meta-analysis of 1462 patients.

I. Porto, P. Stella, R. Fattori, 2013, International journal of cardiology.

Clinical and biomechanical behavior of a platinum-chromium stent platform in a large all-comer single-center population: insights from the Novara-PROMETEUS registry.

I. Porto, R. Fattori, A. Rognoni, 2013, The Journal of invasive cardiology.

Pharmacological adjuvant therapies in primary coronary interventions: bivalirudin.

A. Rognoni, G. Secco, A. Lupi, 2013, Cardiovascular & hematological agents in medicinal chemistry.

Meta‐analysis of bioabsorbable versus durable polymer drug‐eluting stents in 20,005 patients with coronary artery disease: An update

I. Porto, R. Fattori, A. Rognoni, 2014, Catheterization and cardiovascular interventions.